Alpine Associates Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Alpine Associates Management’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,419,100	Closed	-$39.7M	–	62
2019 Q3	$39.7M	Buy	+1,419,100	New	+$23M	1.3%	27

Alpine Associates Management's DOVA Position: Q4 2019 in Review

Alpine Associates Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 1,419,100 shares — an estimated $39.7M sold.

Alpine Associates Management first reported a position in DOVA in Q3 2019 and held it in 1 quarter. The position peaked at $39.7M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Alpine Associates Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Alpine Associates Management sold 1,419,100 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $39.7M.
Alpine Associates Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
Alpine Associates Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $39.7M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Alpine Associates Management's 13F filing for Q4 2019, filed 13 Feb 2020.